Recent Drug Development Research for January 2025
2022 Global Forecast for Immunotherapy Drugs (2023-2028 Outlook)-High Tech & Emerging Markets Report
Topics: Antibody Technologies, Drug Development, Cancer Treatment, Drug Discovery
Regions: Global
| Global Biosensors in Life Sciences Market 2021-2025
Topics: Research & Development, Drug Development, Biopharmacology, Drug Discovery
Regions: Global
| Global Biosensors Market 2022-2026
Topics: Drug Development
Regions: Global
| U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 20
Topics: Drug Development, EMR (Electronic Medical Record), Pharmacy & Distribution, Drug Discovery, CNS/Neurology, Oncology/Hematology
Regions: United States, Global
| NGS Automation Market By Product (Platform, Consumables), Sequencing Type (Whole Genome, Exome, Targeted), Application (Drug Discovery, Diagnostics), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Global Forecast to 2029
Topics: Research & Development, Drug Development, Drug Discovery
Regions: Global
| RWE Oncology Market by Component (Datasets [EHR, Claims, Cancer Registries], Consulting & Analytics Services), Application (Drug Development, Approval, Market Access, Post-market Surveillance), End User (Pharma, Payer) - Global Forecast to 2029
Topics: Drug Development, Personalized Medicine, Cancer Treatment, EMR (Electronic Medical Record), Pharmacy & Distribution, Drug Discovery, Big Data, Oncology/Hematology
Regions: Global
| Coronavirus Disease 2019 (COVID-19) Clinical Trials - Overview, Landscape, Trial using Vaccines vs. Therapeutics,and Trials Impacted by COVID-19
Topics: Research & Development, Drug Development, COVID-19/Coronavirus, Public Health, Vaccines, Drug Discovery, Clinical Trial, Pandemic Vaccines
| Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Glycoprotein 41 (gp41) - Drugs in Development, 2021
Topics: Antibody Technologies, Drug Development, AIDS, HIV & STDs, Drug Discovery
| C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Benign Prostatic Hyperplasia (Womens and Male Health) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Men's Health
| Secondary (Hypogonadotropic) Hypogonadism (Womens and Male Health) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Women's Health, Men's Health
| Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Obesity (Metabolic Disorder) - Drugs in Development, 2021
Topics: Drug Development, Obesity, Diabetes, Drug Discovery
| Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Pain, Drug Discovery, Orthopedics
| Axial Spondyloarthritis (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Arthritis, Drug Discovery
| Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021
Topics: Drug Development, Arthritis, Drug Discovery
| Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Chondrosarcoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
| Anaplastic Oligoastrocytoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Oncology/Hematology
| Neuroblastoma (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, CNS/Neurology, Oncology/Hematology
| Gallbladder Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Oncology/Hematology
Regions: Global
| Endometrial Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Vaginal Cancer (Oncology) - Drugs in Development, 2021
Topics: Drug Development, Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Drugs in Development, 2021
Topics: Drug Development, Coagulation, Drug Discovery
| Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021
Topics: Drug Development, Diabetes, Drug Discovery
| Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery
| Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021
Topics: Enzymes, Drug Development, Drug Discovery
| Ageing (Other Diseases) - Drugs in Development, 2021
Topics: Drug Development, Drug Discovery, Gerontology/Aging
| RAF Proto Oncogene Serine/Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Prescription Drugs, Drug Discovery
| Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021
Topics: Drug Development, Research & Development, Drug Discovery
| Serine/Threonine Protein Kinase A Raf (Proto Oncogene A Raf or Proto Oncogene Pks or ARAF or EC 2.7.11.1) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Toll Like Receptor 4 (hToll or CD284 or TLR4) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021
Topics: Drug Development, Drug Discovery
| Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Cardiovascular
| Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Intermittent Claudication Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
|
Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
